SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
236 I agree, I'd sit tight before jumping into BGEN for a bit. I've done Annie-4/15/1997
235 since it is now trading at 29 I would say wait - I jumped in front of this knifFlan-4/15/1997
234 BGEN trading at 31 any comments if I should buy or wait? Thanks, NicolaNicola Dinisi-4/15/1997
233 Vector, thanks for the advice about Viragen. Atypically I got excited about thHarold Engstrom-4/15/1997
232 <Picture: Yahoo! The Motley Fool> THEÿ MOTLEYÿ FOOL - Apr 14 robert cartelli-4/14/1997
231 BIOGEN INC ( BGEN )Number of brokers recommending as: -------------------------robert cartelli-4/14/1997
230 Rick, thanks for an excellent explaination of the BGEN patent status. I'm nVector1-4/14/1997
229 Great post Rick!Harold Engstrom-4/14/1997
228 Reply re: patents... Vector1: This is a reply that I was preparing to an earlRick Lundberg-4/14/1997
227 CV Therapeutics and Biogen Begin Phase II Clinical Trial of CVT-124 for Congestrobert cartelli-4/14/1997
226 SHDU, I disagree with your premise. Avonex sales of course have slowed from thVector1-4/14/1997
225 Vector, I agree that Biogen is a fine company and has huge potential. For all tHarold Engstrom-4/13/1997
224 Eric, there is already a thread on Viragen here on Silicon investor. It isnHarold Engstrom-4/13/1997
223 Why does the momentum of Avonex sales slowed so much? Does this mean $60 millioshdu-4/12/1997
222 Harold, Does viragen has clinical trial going with their omniferon? If so, at wshdu-4/12/1997
221 BIOGEN's drop today is a massive overreaction to a Cowan downgrade to buy fVector1-4/12/1997
220 Harold: Can you maybe start another thread on Viragen? It sounds interesting. Eric Tianli Wen-4/11/1997
219 I spoke with a representative of Viragen, the small natural interferon company Harold Engstrom-4/11/1997
218 BIOGEN REPORTS FIRST QUARTER 1997 RESULTS AND COMMENCEMENT OF NEW CLINICAL TRIARick Lundberg-4/10/1997
217 Eric, I'm not buying back yet. $38 doesn't seem like a screaming "Harold Engstrom-4/10/1997
216 Rick: According to your reply earlier to Harold. This is the "Fies" Eric Tianli Wen-4/9/1997
215 BIOGEN ANNOUNCES THAT ITS BETA INTERFERON PATENT IS REVOKED BY EUROPEAN PATENTRick Lundberg-4/9/1997
214 Stan, I think we should all remember that things are not black and white; I haRick Lundberg-4/7/1997
213 The effect of the Hirulog deal will indeed be in the first quarter, but the upfRick Lundberg-4/7/1997
212 Annette, If you read the press release on Copaxone carefully, it is anything bStanley Cowen-4/5/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):